Noradrenergic dysfunction and antidepressant treatment response

By Correa H.   Duval F.   Claude M.M.   Bailey P.   Tremeau F.   Diep T.S.   Crocq M.-A.   Castro J.O.   Macher J.-P.  

European Neuropsychopharmacology, Vol. 11, Iss. 2, 2001-04 ,pp. : 163-168

Elsevier

Access to resources Recommend Favorite

Haloperidol and reduced haloperidol discriminate sigma receptor subtypes in the neuronal response to N-methyl-D-aspartate in the rat hippocampus

By Monnet F.P.   Bowen W.D.   Baulieu E.E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 333-334

Elsevier

Access to resources Recommend Favorite

Occupancy of dopamine D₁, D₂ and serotonin_2A receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol

By Reimold M.   Solbach C.   Noda S.   Schaefer J.-E.   Bartels M.   Beneke M.   Machulla H.-J.   Bares R.   Glaser T.   Wormstall H.  

Psychopharmacology, Vol. 190, Iss. 2, 2007-02 ,pp. : 241-249

Springer Publishing Company

Access to resources Recommend Favorite

Frequency of Extrapyramidal Adverse Reactions in Schizophrenic Outpatients Treated with Risperidone, Olanzapine, Quetiapine or Haloperidol: Results of the EIRE Study

By Bobes J.  

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 609-622

Adis International

Access to resources Recommend Favorite

Haloperidol: Severe haloperidol intoxication?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1224, 2008-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite